Items where Author is "Timper, K."

2016

Cavelti-Weder, C. and Timper, K. and Seelig, E. and Keller, C. and Osranek, M. and Lassing, U. and Spohn, G. and Maurer, P. and Muller, P. and Jennings, G. T. and Willers, J. and Saudan, P. and Donath, M. Y. and Bachmann, M. F.. (2016) Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes. Molecular Therapy, 24 (5). pp. 1003-1012.

Timper, K. and Dalmas, E. and Dror, E. and Rutti, S. and Thienel, C. and Sauter, N. S. and Bouzakri, K. and Bedat, B. and Pattou, F. and Kerr-Conte, J. and Boni-Schnetzler, M. and Donath, M. Y.. (2016) Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells. Gastroenterology, 151 (1). pp. 165-179.

2015

Sauter, N. S. and Thienel, C. and Plutino, Y. and Kampe, K. and Dror, E. and Traub, S. and Timper, K. and Bedat, B. and Pattou, F. and Kerr-Conte, J. and Jehle, A. W. and Boni-Schnetzler, M. and Donath, M. Y.. (2015) Angiotensin II Induces Interleukin-1β–Mediated Islet Inflammation and β-Cell Dysfunction Independently of Vasoconstrictive Effects. Diabetes, 64 (4). pp. 1273-1283.

Timper, K. and Fenske, W. and Kuhn, F. and Frech, N. and Arici, B. and Rutishauser, J. and Kopp, P. and Allolio, B. and Stettler, C. and Muller, B. and Katan, M. and Christ-Crain, M.. (2015) Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. Journal of Clinical Endocrinology and Metabolism, 100 (6). pp. 2268-2274.

Timper, K. and Seelig, E. and Tsakiris, D. A. and Donath, M. Y.. (2015) Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications, 29 (7). pp. 955-960.

2013

Biason-Lauber, A. and Boni-Schnetzler, M. and Hubbard, B. P. and Bouzakri, K. and Brunner, A. and Cavelti-Weder, C. and Keller, C. and Meyer-Boni, M. and Meier, D. T. and Brorsson, C. and Timper, K. and Leibowitz, G. and Patrignani, A. and Bruggmann, R. and Boily, G. and Zulewski, H. and Geier, A. and Cermak, J. M. and Elliott, P. and Ellis, J. L. and Westphal, C. and Knobel, U. and Eloranta, J. J. and Kerr-Conte, J. and Pattou, F. and Konrad, D. and Matter, C. M. and Fontana, A. and Rogler, G. and Schlapbach, R. and Regairaz, C. and Carballido, J. M. and Glaser, B. and McBurney, M. W. and Pociot, F. and Sinclair, D. A. and Donath, M. Y.. (2013) Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell metabolism, Vol. 17, H. 3. pp. 448-455.

Timper, K. and Hruz, P. and Beglinger, C. and Donath, M. Y.. (2013) Infliximab in the treatment of Crohn disease and type 1 diabetes. Diabetes care, Vol. 36, H. 7 , e90-e91.

2012

Timper, K. and Donath, M. Y.. (2012) Diabetes mellitus Type 2 - the new face of an old lady. Swiss medical weekly, Vol. 142 , w13635.

2010

Fischer, M. and Timper, K. and Radimerski, T. and Dembinski, K. and Frey, D. M. and Zulewski, H. and Keller, U. and Müller, B. and Christ-Crain, M. and Grisouard, J.. (2010) Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes, Obesity and Metabolism, 12 (4). pp. 356-359.

2007

Seboek, D. and Eberhardt, M. and Barbero, A. and Linscheid, P. and Timper, K. and Martin, I. and Keller, U. and Muller, B. and Zulewski, H.. (2007) Bone marrow derived mesenchymal stem cells isolated from patients with diabetes mellitus type 1 are able to induce a pancreatic endocrine genes in vitro. Journal of stem cells & regenerative medicine, Vol. 2, H. 1. pp. 102-103.